trans-Bis(2,5-dioxopyrrolidin-1-yl) cyclohexane-1,4-dicarboxylate, 98%, 1g

2-Ethoxybenzaldehyde, 95.0%, 500g

4-Nitro-5-(propan-2-yl)-1H-pyrazole-3-carboxylic acid, 95.0%, 100mg

3-(Difluoromethyl)-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1-(tert-butoxycarbonyl)piperidin-4-yl)butanoic acid, 97%, 1g

1-(DIFLUOROMETHYL)-1H-PYRAZOL-4-AMINE, 95.0%, 5g

(2R,5S)-2,5-Dimethylmorpholine, 98+%, 100mg

(3R,4R)-tert-Butyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate, 1g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 95.0%, 5g

6-Bromo-2-chlorobenzothiazole, 99.00%, 25g

4-Bromo-2-iodo-1-(trifluoromethyl)benzene, 95.0%, 5g

6-Iodo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine, 95+%, 1g

(3-Ethoxycarbonyl-5-nitrophenyl)boronic acid, 95.0%, 100g